Correlation Between Pmv Pharmaceuticals and Entrada Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Entrada Therapeutics, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Entrada Therapeutics.
Diversification Opportunities for Pmv Pharmaceuticals and Entrada Therapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pmv and Entrada is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Entrada Therapeutics go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Entrada Therapeutics
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Entrada Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 1.02 times less risky than Entrada Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Entrada Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 1,684 in Entrada Therapeutics on August 25, 2024 and sell it today you would earn a total of 196.00 from holding Entrada Therapeutics or generate 11.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Entrada Therapeutics
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Entrada Therapeutics |
Pmv Pharmaceuticals and Entrada Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Entrada Therapeutics
The main advantage of trading using opposite Pmv Pharmaceuticals and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.| Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
| Entrada Therapeutics vs. Molecular Partners AG | Entrada Therapeutics vs. Pmv Pharmaceuticals | Entrada Therapeutics vs. Monte Rosa Therapeutics | Entrada Therapeutics vs. Vigil Neuroscience |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |